First-in-human study to assess safety, tolerability, pharmacokinetics, and pharmacodynamics of the anti-CD27L antibody-drug conjugate AMG 172 in patients with relapsed/refractory renal cell carcinoma
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Weitere Verfasser: | |
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
26 March 2019
|
| In: |
Cancer chemotherapy and pharmacology
Year: 2019, Jahrgang: 83, Heft: 6, Pages: 1057-1063 |
| ISSN: | 1432-0843 |
| DOI: | 10.1007/s00280-019-03796-4 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s00280-019-03796-4
|
| Verfasserangaben: | Christophe Massard, Jean‑Charles Soria, Jürgen Krauss, Michael Gordon, Albert Craig Lockhart, Erik Rasmussen, Vijay V. Upreti, Sonal Patel, Gataree Ngarmchamnanrith, Haby Henary |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1669431525 | ||
| 003 | DE-627 | ||
| 005 | 20230427111654.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 190718s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00280-019-03796-4 |2 doi | |
| 035 | |a (DE-627)1669431525 | ||
| 035 | |a (DE-599)KXP1669431525 | ||
| 035 | |a (OCoLC)1341234009 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Massard, Christophe |0 (DE-588)119084673X |0 (DE-627)1669433897 |4 aut | |
| 245 | 1 | 0 | |a First-in-human study to assess safety, tolerability, pharmacokinetics, and pharmacodynamics of the anti-CD27L antibody-drug conjugate AMG 172 in patients with relapsed/refractory renal cell carcinoma |c Christophe Massard, Jean‑Charles Soria, Jürgen Krauss, Michael Gordon, Albert Craig Lockhart, Erik Rasmussen, Vijay V. Upreti, Sonal Patel, Gataree Ngarmchamnanrith, Haby Henary |
| 264 | 1 | |c 26 March 2019 | |
| 300 | |a 7 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 18.07.2019 | ||
| 700 | 1 | |a Krauß, Jürgen |d 1960- |0 (DE-588)120665301 |0 (DE-627)70490778X |0 (DE-576)292329083 |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Cancer chemotherapy and pharmacology |d Berlin : Springer, 1978 |g 83(2019), 6, Seite 1057-1063 |h Online-Ressource |w (DE-627)253390435 |w (DE-600)1458488-8 |w (DE-576)072283467 |x 1432-0843 |7 nnas |a First-in-human study to assess safety, tolerability, pharmacokinetics, and pharmacodynamics of the anti-CD27L antibody-drug conjugate AMG 172 in patients with relapsed/refractory renal cell carcinoma |
| 773 | 1 | 8 | |g volume:83 |g year:2019 |g number:6 |g pages:1057-1063 |g extent:7 |a First-in-human study to assess safety, tolerability, pharmacokinetics, and pharmacodynamics of the anti-CD27L antibody-drug conjugate AMG 172 in patients with relapsed/refractory renal cell carcinoma |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s00280-019-03796-4 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20190718 | ||
| 993 | |a Article | ||
| 994 | |a 2019 | ||
| 998 | |g 120665301 |a Krauß, Jürgen |m 120665301:Krauß, Jürgen |d 910000 |e 910000PK120665301 |k 0/910000/ |p 3 | ||
| 999 | |a KXP-PPN1669431525 |e 3494793646 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Gesehen am 18.07.2019"],"person":[{"role":"aut","given":"Christophe","display":"Massard, Christophe","family":"Massard"},{"role":"oth","given":"Jürgen","display":"Krauß, Jürgen","family":"Krauß"}],"title":[{"title_sort":"First-in-human study to assess safety, tolerability, pharmacokinetics, and pharmacodynamics of the anti-CD27L antibody-drug conjugate AMG 172 in patients with relapsed/refractory renal cell carcinoma","title":"First-in-human study to assess safety, tolerability, pharmacokinetics, and pharmacodynamics of the anti-CD27L antibody-drug conjugate AMG 172 in patients with relapsed/refractory renal cell carcinoma"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"eki":["1669431525"],"doi":["10.1007/s00280-019-03796-4"]},"language":["eng"],"physDesc":[{"extent":"7 S."}],"recId":"1669431525","name":{"displayForm":["Christophe Massard, Jean‑Charles Soria, Jürgen Krauss, Michael Gordon, Albert Craig Lockhart, Erik Rasmussen, Vijay V. Upreti, Sonal Patel, Gataree Ngarmchamnanrith, Haby Henary"]},"relHost":[{"pubHistory":["1.1978 -"],"disp":"First-in-human study to assess safety, tolerability, pharmacokinetics, and pharmacodynamics of the anti-CD27L antibody-drug conjugate AMG 172 in patients with relapsed/refractory renal cell carcinomaCancer chemotherapy and pharmacology","origin":[{"dateIssuedKey":"1978","publisherPlace":"Berlin ; Heidelberg","publisher":"Springer","dateIssuedDisp":"1978-"}],"part":{"volume":"83","pages":"1057-1063","year":"2019","text":"83(2019), 6, Seite 1057-1063","issue":"6","extent":"7"},"physDesc":[{"extent":"Online-Ressource"}],"id":{"issn":["1432-0843"],"zdb":["1458488-8"],"eki":["253390435"]},"language":["eng"],"titleAlt":[{"title":"CCP"}],"recId":"253390435","title":[{"title_sort":"Cancer chemotherapy and pharmacology","title":"Cancer chemotherapy and pharmacology","subtitle":"CCP"}],"note":["Gesehen am 02.12.05","Fortsetzung der Druck-Ausgabe","Ungezählte Beil. ab 38.1996: Supplement"],"type":{"bibl":"periodical","media":"Online-Ressource"}}],"origin":[{"dateIssuedDisp":"26 March 2019","dateIssuedKey":"2019"}]} | ||
| SRT | |a MASSARDCHRFIRSTINHUM2620 | ||